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Abstract
Despite recent evidence implicating the nucleus accumbens (NAc) as causally involved in the 
transition to chronic pain in humans, underlying mechanisms of this involvement remain entirely 
unknown. Here we elucidate mechanisms of NAc reorganizational properties (longitudinally and 
cross-sectionally), in an animal model of neuropathic pain (spared nerve injury, SNI). We 
observed inter-related changes: 1) In resting-state fMRI, functional connectivity of the NAc to 
dorsal striatum and cortex was reduced 28 days (but not 5 days) after SNI; 2) contralateral to SNI 
injury, gene expression of NAc dopamine 1A, 2, and κ-opioid receptors decreased 28 days after 
SNI; 3) In SNI (but not sham) covariance of gene expression was upregulated at 5 days and settled 
to a new state at 28 days; and 4) NAc functional connectivity correlated with dopamine receptor 
gene expression and with tactile allodynia. Moreover, interruption of NAc activity (via lidocaine 
infusion) reversibly alleviated neuropathic pain in SNI animals. Together, these results 
demonstrate macroscopic (fMRI) and molecular reorganization of NAc and indicate that NAc 
neuronal activity is necessary for full expression of neuropathic pain-like behavior.
Introduction
Concepts regarding the role of nucleus accumbens (NAc) in pain, and in chronification of 
pain, are undergoing rapid advances. Until recently this nucleus was thought to be primarily 
involved in evaluating reward signals, yet new evidence shows that it also encodes salience 
for pain, and value for pain relief and that NAc valuation of acute analgesia is distorted in 
chronic pain patients [9; 12; 13; 54; 64; 65]. Recent evidence indicates that increased 
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functional connectivity between NAc and the prefrontal cortex is predictive of the transition 
from acute to chronic pain one year prior to pain chronification [10]. Despite these 
advances, the mechanistic implications of the macroscopic human brain imaging-based 
findings remain unknown; even though they were predicated on the hypothesis that NAc 
dopaminergic learning mechanisms may play an essential role in pain chronification [7].
The NAc is a central component of the mesocorticolimbic system [5; 19; 31]; a brain 
network closely associated with emotional learning, motivated and addictive behavior, in 
which dopaminergic neurotransmission and modulation are thought to supply the critical 
learning signal. Knowledge of the role of the mesolimbic circuitry in pain is increasing. The 
association between mesolimbic circuitry and neural substrates of pain and analgesia has 
been considered in the past decades [29; 37; 53]; for noxious or aversive conditions both 
excitatory and inhibitory responses of dopaminergic neurons have been observed [16; 23; 
43; 50; 62; 68], both increases and decreases in extracellular dopamine are reported [11; 51], 
and corresponding results are found in human studies [44; 46]. Moreover, in patients with 
central disorders such as schizophrenia, Parkinson’s disease, substance abuse, and mood and 
anxiety disorders, pain sensitivity is altered, presumably as a consequence of changes in the 
dopaminergic system [1; 42; 71], and animal studies implicate dopamine in acute and 
neuropathic conditions [6; 26; 60]. Yet, the mechanistic role of NAc in pain chronification 
remains unknown.
The present study was designed to interrogate NAc properties in the spared nerve injury 
(SNI) model of neuropathic pain to evaluate cross-species correspondences, and to inform 
the relationship between fMRI macroscopic measures and related molecular mechanisms. 
The SNI model is a robust rodent model of neuropathic pain in which animals develop 
lifelong pain following nerve injury. It is used here as a tool for detecting how persistent 
neuropathic pain may affect the NAc. Given that the critical role of NAc in human pain 
chronification was identified in a combined longitudinal and cross-sectional study, we 
adopted a similar approach in the rat and tracked NAc functional connectivity and receptor 
properties, as animals transitioned from healthy to neuropathic pain behavior. Furthermore, 
we examined the effects of reversibly interrupting NAc activity on modulation of 
neuropathic behavior.
Methods
Animals
Adult male Sprague Dawley rats (Harlan, Indianapolis, IN; 200 – 250g) were used 
throughout the experiments. Animals were housed on soft bedding in groups of three per 
cage on a 12-h light/dark cycle in a temperature-controlled environment (21 ± 2°C) with 
food and water available ad libitum. For all animals, handling and testing were performed 
during the light period. To minimize stress, they were handled regularly before injury and 
before behavioral testing. All experimental procedures were approved by the Northwestern 
University Institutional Animal Care and Use Committee. Behavioral measures and initial 
fMRI data analyses were performed in a blinded fashion.
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Experimental Design
Experiment A—In this experiment, we tested how peripheral nerve injury induces changes 
in NAc due to persistent neuropathic pain. We tracked NAc properties cross-sectionally (in 
comparison to sham animals) from pre-injury (Day-2) to persistent pain (Day5 and Day28), 
using mRNA receptor expression, fMRI functional connectivity, and behavior. The 
experimental paradigm is summarized in Fig. 1A. Animals were divided into two groups: 
the Short Term group sacrificed at Day5, and the Long Term group sacrificed at Day28 
(MRI: Day5: SNI = 10, sham = 12 animals; Day28: SNI = 13, sham = 11 animals. RT-
qPCR: Day5: SNI = 14, sham = 13 animals; Day28: SNI = 14, sham = 12 animals). Because 
physiological recording was used for fMRI data pre-processing, rats with incomplete 
physiological recordings during the scans were excluded from the fMRI study; however 
these rats were still included in the receptor gene expression analysis. fMRI data was 
obtained before injury, as well as on the day before they were sacrificed to extract NAc 
tissue for mRNA receptor expression. Mechanical allodynia was assessed the day before 
each fMRI scan.
Experiment B—Modulation of neuropathic behavior was investigated by blocking NAc 
activity using a brain microinjection technique. A different set of SNI animals received 
chronic infusion of lidocaine 2% (n = 8) or saline as vehicle control (n = 7) in the NAc for 
14 days. The experimental paradigm is summarized in Fig. 2. An Alzet mini pump was 
implanted on the side (right) contralateral to the paw (left) that received SNI injury, with 
both procedures performed on the same day. Behavioral tests for mechanical and cold 
allodynia were assessed twice before injury (around Day-2 for implanting the pump and 
injuring the peripheral nerve) as well as on Day4, Day7, Day10, Day14, Day17 and Day20.
Spared Nerve Injury (SNI)
SNI was used as an animal model of persistent peripheral neuropathic pain. The SNI model 
has been described previously [24]. Animals were anesthetized with isoflurane (1.5 –2%) 
and a mixture of 30% N2O and 70% O2. The sciatic nerve of the left hind leg was exposed at 
the level of trifurcation into the sural, tibial, and common peroneal nerves. The tibial and 
common peroneal nerves were tightly ligated and severed, leaving the sural nerve intact. 
Animals in the sham injury group served as the control as their sciatic nerves were exposed, 
as in the SNI procedure, but they received no further manipulations.
Test for Mechanical Allodynia
Tactile sensitivity of the hind paw was measured using withdrawal responses to a series of 
von Frey filaments as previously described [20]. Animals were placed in a Plexiglass box 
with a wire grid floor and allowed to habituate to the environment for 10 – 15 minutes. 
Filaments of varying forces (Stoelting Co, USA) were applied to the lateral part of the 
plantar surface of the hind paw. Filaments were applied in either ascending or descending 
strengths to determine the filament strength closest to the hind paw withdrawal threshold. 
Each filament was applied for a maximum of 2 seconds at each trial; paw withdrawal during 
the stimulation was considered a positive response. Given the response pattern and the force 
of the final filament, 50% response threshold (in grams) was calculated [20].
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Test of Cold Allodynia
The measurement of sensitivity to cold consisted of applying 1 drop (about 50µl/site) of 
acetone solution on the lateral hind paw of the animal as previously described [22]. The 
withdrawal reaction of the animals was observed. Half a second and 20 seconds were 
assigned as minimal and maximal cut-off points, respectively. This test was repeated three 
times per paw, at 10-minute intervals. A score ranging from 0 to 4 was used to quantify the 
type of reactions (withdrawal, vocalization, flinching and licking) the animals exhibited to 
the acetone drop. The scores of an animal’s reactions during three times of the test were 
averaged for per paw, and used as the score of the animal.
MRI Acquisition
All MR experiments were carried out on a Bruker 7 T/40 cm horizontal magnet (Clinscan, 
Bruker Biospin, Ettlingen, Germany) with a surface coil. Blood oxygen level-dependent 
(BOLD) contrast-sensitive T2*-weighted gradient-echo echo-planar images were acquired 
for resting state fMRI (rs-fMRI) scans. Each scan consisted of 300 volumes of 14 slices 
acquisition (repetition time (TR) of 1.3 seconds, echo time (TE) of 25 milliseconds, flip 
angle = 60°, 1.0 mm slice thickness, and 0.5 × 0.5 mm2 in-plane resolution). A high-
resolution T2-weighted RARE anatomical reference was acquired for each animal (1.0 mm 
slice thickness and 0.273 × 0.273 mm2 in-plane resolution). An additional T2-weighted 
RARE anatomical scan with the same geometry as the functional image (1 mm slice 
thickness and 0.5 × 0.5 mm2 in-plane resolution) was also acquired and used as a low-
resolution anatomical reference.
Anesthesia was induced and maintained during the experiments with isoflurane (1.75 – 
2.5%) mixed with air. Body temperature, respiratory rate, and heart rate were monitored and 
recorded during scans (Model 1025; SA Instruments, Stony Brook, NY, USA). The 
monitoring system was operated using a fiber optic temperature probe, respiration pad and 
fiber optic pulse oxymeter. Respiratory and cardiac waves were recorded during image 
acquisition with a temporal resolution of 0.001 kHz. To maintain body temperature around 
37°C during the imaging session, a feedback-controlled water circulation system (medres, 
Cologne, Germany) was used to supply the base of the cradle. rs-fMRI scans were collected 
only when physiological parameters remained stable for about 10 minutes.
Image Preprocessing
The rs-fMRI data was preprocessed with AFNI (http://afni.nimh.nih.gov) and FSL 5.1 
(FMRIB's Software Library, http://www.fmrib.ox.ac.uk/fsl). The fMRI were first skull 
stripped and preprocessed using AFNI by applying de-spiking, removal of physiological 
artifacts from respiration and heartbeat, and correction for slice timing. Rats that had 
incomplete respiratory and cardiac recordings were discard from MRI data analysis. The 
images were then processed using FSL for correction for motion, spatially smoothed with a 
Gaussian kernel of 0.8 mm FWHM and high pass filtered with a cutoff of 100 seconds.
Volumes from functional images were registered to a standard space with a three-step 
process. Images were first aligned with the individual’s low-resolution anatomical image 
followed by alignment with the individual’s high-resolution anatomical image, and then co-
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registered to a standard space. Average time courses from all of the voxels inside whole 
brain, white matter (WM) and cerebrospinal fluid (CSF) were extracted. Confounding 
regressors that modeled global whole brain, WM and CSF signals and six motion 
parameters, including translations and rotations, were removed from images through linear 
regression.
Functional Connectivity Analysis
rs-fMRI connectivity was evaluated using a seed-based correlational approach. Based on 
histological characteristics in animals, the NAc is divided into two major sub-territories, the 
core and the shell [27; 41; 48]. Fig. 3A displays the coordinates of seeds for the NAc core 
and shell, which were selected based on the rat MRI atlas [63] and were used for functional 
connectivity analysis. Averaged time course from all of the voxels inside the seed region 
was correlated with every other voxel time course of the brain. Correlation coefficients (r) 
were converted to a normal distribution using Fisher's z transform (z(r)). In order to evaluate 
anesthesia-related global functional connectivity [47], 1000 randomly selected voxels were 
correlated with every other voxel time course of the brain, Fisher’s z transformed, and 
averaged to yield a single index per animal, which represented the anesthesia-related global 
functional connectivity of the animal. No significant difference was found between the 
indices of SNI and sham animals for all experimental conditions (Day-2, Day5 and Day28). 
To diminish anesthesia-related across animal variability, global functional was used as 
confounding regressor in the group-level statistical analysis.
Voxel-wise group-level statistical analysis of functional connectivity were assessed non-
parametrically using the FSL Randomize tool [55]. For each analysis, 5000 random 
permutations were carried out. The analyses were performed only within the gray matter 
mask. All statistical maps were family-wise error (FWE) corrected using P < 0.05, based on 
the threshold-free cluster enhancement (TFCE) statistic image [66].
Gene Expression Analysis
Gene expression was performed on NAc from SNI and sham operated rats at Day5 and 
Day28. Rats were deeply anesthetized with Isoflurane and rapidly decapitated; brains were 
removed while immersed in TBS frozen buffer. Brains were sliced coronally from Bregma 
2.20 to 1.00, allowing easy visualization of the NAc, and contralateral and ipsilateral NAc 
were removed separately and frozen in liquid nitrogen, and stored at − 80°C. RNA was 
extracted using a Qiagen RNeasy RNA extraction kit; DNA contamination was prevented by 
first using a column that binds DNA while allowing RNA to flow through. RNA was reverse 
transcribed into cDNA using Roche’s First Strand cDNA Synthesis kit and oligo dT primers. 
RNA yield and quality was confirmed with Nanodrop analysis.
RT-qPCR was done using a Roche Lightcycler 480 (LC480) with either Roche probes 
master mix or SYBR green master mix, primers (0.4 µM), hydrolysis probes and NAc 
cDNA (primers listed in Table S7). All genes of interest were normalized to the GAPDH 
reference gene. For hydrolysis probe reactions, a single gene of interest was multiplexed 
with the reference gene GAPDH in the same well. Reactions consisted of a 5-minute hot 
start incubation at 95°C, followed by 45 cycles of 10-second at 95°C, 10-second at 60°C, 
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and 1-second at 72°C. Primers were initially validated using a SYBR green RT-qPCR assay, 
which allowed for melting temperature analysis, demonstrating a single peak for each gene 
product. RT-qPCR samples were also run on 1.8% agarose gels to verify single gene 
products. Although primers were intron spanning, cDNA negative and reverse transcriptase 
negative controls were done for genes of interest and did not give a signal. As recommended 
in published guidelines for RT-qPCR methods, all data were efficiency corrected [18]. 
Standard curves were done to calculate reaction efficiency for each gene product using 
dilutions of NAc cDNA. All data were efficiency corrected using Roche LC480 software 
and the delta delta Ct method [61]. For multiplex reactions, efficiency curves were run using 
multiplex parameters, while for SYBR green reactions efficiency curves were done with 
SYBR green reaction mixes. Within the recommendations of the MIQE RT-qPCR 
guidelines, a reference gene can be validated by running another reference gene against it. 
Thus to validate GADPH as a stable reference gene, tubulin was run relative to GAPDH for 
all samples and no differences in tubulin were detected when run against GAPDH. 
According to MIQE guidelines this provides sufficient confidence in GAPDH that it can be 
used as a reference gene on its own [18]. Statistical analyses were done using a two-way 
ANOVA test, with Fisher LSD for post-hoc analysis.
Correlation Analysis
Relationships between NAc functional connectivity, receptor expression, and pain behavior 
were investigated using correlation analysis. Data for correlation analysis were pooled from 
Day5 and Day28, separately for SNI and sham animals. For inter-run calibration for RT-
qPCR, a normalized receptor gene expression was used in the correlation analysis. The 
samples of brain tissue were tested for RT-qPCR in two runs, with each run consisting of 
SNI and sham animals at Day5 and Day28. Thus, a z-score of receptor gene expression was 
calculated with each run in order to calibrate the two runs.
Mini-Pump Insertion
Animals were anesthetized with isofluorane (2 – 3%), and a mixture of 30% N2O and 70% 
O2 and an osmotic mini-pump (ALZET Osmotic Pumps, Model 2002, 200 µl reservoir 
volume, 14 days delivery; 0.5 µl/hr release rate; Cupertino, CA) was implanted 
subcutaneously between the scapular blades. This pump was filled either with saline or 
Lidocaine 2% and connected by a vinyl tube (PVC 60) to a 28-gauge injector (Plastics One, 
Roanoke, VA) that was stereotaxically implanted in the medial shell of NAc, which 
suggested to be hedonic hot spot in the NAc [57], and was contralateral to peripheral nerve 
injury (ML: + 1; DV: - 7; AP: - 1.7, relative to Bregma). Immediately after the pump 
insertion, these animals received an SNI injury.
Histology
At the end of the observation period of the animals for Experiment B, each animal was 
deeply anesthetized (60 mg/kg, nembutal, i.p.) and transcardially perfused with 4% 
paraformaldehyde. The brains were isolated and processed to determine the placement of 
cannulae. For this purpose, serial sections (40 µm thickness) were stained with Cresyl Violet 
stain and screened under the microscope.
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Results
Experiment A
In this experiment, we tested the effects of peripheral nerve injury on extent of information 
sharing between NAc and the rest of the brain, as well as on gene expression in NAc. The 
experimental design is shown in Fig. 1A. Baseline fMRI scans were conducted in rats 2 days 
prior to SNI or sham injury. At either 5 days or 28 days post-injury, SNI and sham injury 
rats were imaged again and sacrificed to assess NAc receptor gene expression. SNI animals 
showed behavioral signs of persistent neuropathic pain, including tactile allodynia after SNI 
injury (Fig. 1B). Von Frey 50% withdrawal thresholds of the injured paw in SNI animals, 
but not sham animals, decreased at Day 5 and persisted at Day 28 (two-way ANOVA, for 
group effect, F(2,86) = 15.93, P < 0.001; Fisher LSD post-hoc comparison for both Day 5 
and Day 28, P < 0.001). No difference in withdrawal thresholds was observed for the 
contralateral paw in SNI or either paw in sham animals (F(2,86) = 0.18, P = 0.83).
The NAc core and shell display overlapping but differential functional 
connections—To identify NAc functional connectivity in healthy conditions, we 
performed a whole-brain functional connectivity analysis using non-parametric permutation 
tests on resting-state fMRI scans acquired prior to injury (Day-2). rs-fMRI connectivity was 
evaluated using a seed-based correlational approach. Resting state analyses detect coherent 
patterns of brain activity in the resting subject, in the absence of a task, by assessing 
functional connectivity between a seed region and other target brain areas [33]. Based on 
histological, track tracing, and physiological characteristics in animals [35], the NAc is 
divided into two major territories, the core and the shell. Both the NAc core and shell 
exhibited extensive significant correlations with sensory and motor regions, prefrontal 
cortical regions, hippocampus, thalamus, and hypothalamus, and both regions showed the 
strongest functional connections with dorsal striatum (CPu, Caudate/Putamen), sensory 
cortex (S1/2), motor cortex (M1/2), insula (Ins), cingulate (Cg), as well as the medial 
(mPFC) and orbital (OFC) prefrontal cortices (Fig. 3B, Table S1 and Table S2).
Despite the large overlap in the NAc core and shell connectivity maps, the core and shell 
were also characterized by differential functional connectivity strengths (Fig. 3C, Table S3 
and Table S4). Specifically, the NAc core showed significantly stronger connectivity to Cg, 
CPu, Ins, OFC, S1/2 (Table S3), whereas the shell exhibited stronger connectivity to the 
hippocampus (Hipp), thalamus (Tha), hypothalamus (Hy), and mPFC (Table S4). In 
addition, the right NAc core showed significantly stronger connectivity to the left NAc core, 
whereas the right NAc shell showed significantly stronger connectivity to the left NAc shell. 
This demonstrated the core and shell were characterized by specific functional connections, 
even with the close proximity of the seeds for functional connectivity analysis.
Reorganization of NAc core and shell functional connections in SNI animals—
Our primary hypothesis was that NAc core and shell are important mediators of chronic 
pain-like behavior following neuropathic injury, which should be reflected in reorganization 
in information sharing between NAc and the rest of the brain. To examine changes 
associated with neuropathic pain, a whole-brain t-test determined group differences between 
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SNI and sham animals at Day-2, as well as Day5 and Day28. At Day-2 and Day5, no 
significant difference of functional connectivity between SNI and sham animals was seen 
(data not shown). At Day28, functional connectivity decreased for contralateral NAc core 
connectivity to the contralateral CPu, bilateral Ins and S1/2, and for ipsilateral NAc core 
connectivity to the contralateral Ins, and bilateral S1/2; for contralateral NAc shell 
connectivity to the bilateral S1/2, and Ins (Fig. 4 and Table S5).
Reduced expression of NAc dopamine type 1a, 2, and kappa-opioid receptors 
in SNI animals—To evaluate NAc receptor gene expression changes with the transition to 
neuropathic pain, reverse transcriptase, quantitative PCR (RT-qPCR) was conducted on 
NAc tissue from SNI and sham animals. To determine the possible lateralization of receptor 
gene expression changes, contralateral and ipsilateral NAc from each animal were collected 
and analyzed separately. In order to relate receptor gene expression to temporal aspects of 
chronification, tissue was collected at Day5 and Day28. Efficiency curves using 10-fold 
dilutions of NAc cDNA were run to validate primer efficiency (Fig. 5A, B for representative 
curves). RT-qPCR products were also run on a gel to verify a single product and confirm 
primer specificity (Fig. 5C). All genes of interest were normalized to the GAPDH reference 
gene and are shown relative to sham animals. Additionally, the properties of NAc ipsilateral 
to SNI were quantified relative to the ipsilateral sham NAc, whereas the NAc contralateral 
to SNI injury was quantified relative to the contralateral sham NAc. As Fig. 5D shows, there 
were no significant changes in the alpha tubulin to GAPDH ratio at either Day5 or Day28 in 
contralateral or ipsilateral NAc, thereby validating the stability of GAPDH as a reference 
gene. This analysis focused on genes that are either of particular interest for NAc function 
(D1, D2) or for pain regulation (opioids cannabinoid receptors). Our analysis revealed no 
significant changes in transcript expression at Day5 or Day28 for the cannabinoid receptor 1 
(CB1), µ-opioid receptor 1 (MOR1), and serotonin1a receptor (5-HT1a) (data not shown). 
Interestingly, the κ-opioid receptor (KOR) transcript showed no significant changes at Day5, 
yet a significant 27% reduction was identified only in contralateral NAc in SNI animals at 
Day28 (two-way ANOVA, post-hoc Fisher LSD comparison, P = 0.03), relative to sham 
animals (Fig. 5E). Furthermore, the DR1a transcript also showed no significant changes at 
Day5, but it showed a significant 30% reduction in the contralateral NAc only at Day28 (P = 
0.02) (Fig. 5F). The DR2 transcript also showed no significant changes at Day5, yet a 
significant 21% reduction in the contralateral NAc at Day28 was observed (P = 0.01) (Fig. 
5G). These data demonstrate that peripheral nerve injury induces significant, time dependent 
changes in the expression of several important genes within the NAc. Moreover, these 
changes are lateralized, occurring in the NAc contralateral to injury. Although no significant 
changes were detected in the NAc ipsilateral to injury, there were trends for a reduction in 
DR1a (P = 0.12) and DR2 (P = 0.11) receptor gene expression in SNI animals at Day28.
We also observe that the interaction between receptor genes (influence of one receptor on 
another) shifts in time after SNI. The latter was quantitated by the covariance matrix for 
receptor gene expression in NAc at Day5 and Day28 in SNI and sham animals, and 
represented as a receptor- network connectivity graph (Fig. 6). We observed a general 
upregulation of covariance between the genes examined in SNI animals at Day5, which 
subsequently (at Day28) subsided to levels comparable to sham animals. Across both groups 
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and time intervals the expression of DR1a and DR2 (DR1/DR2), and the expression of CB1 
and 5-HT1a (CB1/5-HT1a), were positively interrelated within and across contralateral and 
ipsilateral NAc, whereas these gene pairs were negatively interrelated with each other. If we 
treat the measured pair-wise correlations as random samples, then we can quantify these 
general observations. The covariance matrix for DR1a, DR2, both within and across 
contralateral and ipsilateral NAc (Table S6A) shows a strong group by time interaction 
(F(1,20) = 15.2, P < 0.001), with a post-hoc Bonferroni comparison showing significantly 
higher covariance in SNI animals at Day5 (mean strength = 0.87, S.E.M. = 0.07) in contrast 
to sham animals at Day5 (mean strength = 0.44, P < 0.001). No group differences were 
identified at Day28 (SNI mean strength = 0.60; sham = 0.74). A similar analysis for the CB1 
and 5-HT1a covariance matrix (Table S6B) shows only a time effect (F(1,20) = 7.5, P < 
0.01), with a higher overall covariance strength at Day5 (mean strength = 0.65 with S.E.M. 
= 0.06), in contrast to Day28 (mean strength = 0.40). We also tested the covariance matrix 
linking the DR1a/DR2 with the CB1/5HT1a (Table S6C). The covariance matrix was 
significant for group (F(1,20) = 26.9, P < 10−5), time (F(1,20) = 5.1, P < 0.03), and group-
by-time interaction (F(1,20) = 10.4, P < 0.005). Post-hoc Bonferroni comparisons indicated 
significantly higher negative covariance in SNI animals at Day5 (mean strength = - 0.61, 
S.E.M. = 0.04), in contrast to sham animals at Day5 (mean strength = - 0.19, P < 10−6). 
Again, no difference between the groups was found at Day28 (SNI mean strength = - 0.33; 
sham = - 0.24). Thus, we observe that the positive strength of the DR1a/DR2 is elevated, 
whereas the negative interaction between the DR1a/DR2 and CB1/5-HT1a is enhanced, 
early after peripheral nerve injury in the SNI animals.
Relating NAc functional connectivity to receptor gene expression and to pain 
behavior—We performed correlation analyses to explore the longitudinal association 
between changes in functional connectivity in SNI animals with pain behavior and receptor 
gene expression. First, functional connectivity of contralateral NAc core to the brain voxels, 
which was previously identified as decreased in SNI animals and was contralateral to injury, 
was averaged for this correlation analysis. This contralateral NAc core functional 
connectivity was significantly different among group and across time (two-way ANOVA, 
for group-by-time effect, F(2,77) = 6.31, P = 0.014; Fisher LSD post-hoc comparison on 
between SNI and sham animals at Day28, P < 0.001; difference between SNI animals at 
Day28 and Day-2, P = 0.002) (Fig. 7A bar graph). This functional connectivity (pooling the 
Day5 and Day28 time points) exhibited a significant negative correlation with DR2 gene 
expression in SNI animals (R = - 0.52, P = 0.01), but not in sham animals (R = - 0.13, P = 
0.57), and also showed trends with SNI DR1a (R = - 0.32, P = 0.13) and KOR (R = −0.36, P 
= 0.09, data not shown) gene expression, and was also significantly positively correlated 
with pain behavior in SNI animals (R = 0.62, P = 0.002), but not in sham animals (R = - 
0.08, P = 0.73) (Fig. 7A scatter plots). In addition, shell functional connectivity of 
contralateral NAc to the brain voxels, which were previously identified as decreased in SNI 
animals and was contralateral to injury, was averaged for this correlation analysis. This 
contralateral NAc shell functional connectivity was significantly different among group and 
across time (two-way ANOVA, for group-by-time effect, F(2,77) = 4.71, P = 0.033; Fisher 
LSD post-hoc comparison on difference between SNI and sham animals at Day28, P < 
0.001; difference between SNI animals at Day28 and Day-2, P = 0.03) (Fig. 7B bar graph). 
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This functional connectivity (pooling the Day5 and Day28 time points) approached a 
borderline of significance of correlation with DR2 gene expression in SNI animals (R = - 
0.38, P = 0.08) but not in sham animals (R = - 0.12, P = 0.58), and also showed trends with 
SNI DR1a (R = - 0.25, P = 0.24) and KOR (R = −0.30, P = 0.16, data not shown) gene 
expression, but did not correlate with pain behavior in SNI animals (R = 0.24, P = 0.26) and 
sham animals (R = - 0.02, P = 0.92) (Fig. 7B scatter plots). No correlation was found 
between functional connectivity and alpha tubulin expression (data not shown). These 
results indicate that peripheral nerve injury-induced modulation of NAc connectivity in SNI 
animals is differentially related with changes in DR2 gene expression and to mechanical 
allodynia.
Experiment B
Continuous lidocaine infusion in NAc decreases mechanical and cold 
hypersensitivity in SNI animals—There is good evidence that plasticity of the NAc is 
necessary for the consolidation of appetitive instrumental memories [38]. Appetitive 
instrumental memory is a form of associative memory. It is the process by which new 
rewards are learned and acquire their motivational salience. Within this context, the 
reorganization of NAc functional connectivity observed in SNI animals (Experiment A) can 
be interpreted as evidence for the involvement of NAc-mediated learning processes in the 
transition to a neuropathic state. To test this hypothesis directly in a new cohort of animals, 
we examined the effects of reversibly interrupting neuronal activity of NAc (by a 2-week 
continuous infusion of lidocaine 2%, started at the time when peripheral nerve injury was 
inflicted), on the maintenance and temporal evolution of signs for neuropathic pain-like 
behavior (Fig. 2).
Lidocaine (targeting mainly the contralateral medial shell of NAc (Fig. 8A), which is 
suggested to be hedonic hot spot in the NAc [57], significantly decreased the magnitude of 
tactile allodynia during treatment (two-way repeated-measures ANOVA, with time as repeat 
measure for group effect, F(1,13) = 7.19, P = 0.02) (Fig. 8B). After cessation of treatment at 
Day14, lidocaine-infused animals progressively returned to tactile sensitivity levels of saline 
infused animals. There was no difference between groups for the tactile thresholds of the 
uninjured paw at any time point (data not shown).
Lidocaine-infused animals also exhibited a decrease in cold allodynia during lidocaine 
treatment compared with the saline-infused animals (Fig. 8C). Cold allodynia score was 
significantly lower in lidocaine-infused animals compared to saline-infused animals during 
the treatment (F(1,13) = 9.19, P = 0.01).
Discussion
We demonstrate differential functional connectivity of NAc core and shell, in the healthy 
rat, with cortical and sub-cortical regions. This functional connectivity reorganization was 
not detected at 5 days but rather 28 days following neuropathic injury, and not in sham 
animals. Functional connectivity primarily exhibited a long-term reduction in strength of 
communication between ventral and dorsal striatum and to specific cortical regions. This 
reduction of functional connectivity is specific to the location of the seed and to the body 
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side where peripheral nerve injury was inflicted. RT-qPCR complemented the fMRI results 
by showing that gene expression for multiple receptors decreased at Day 28 only in NAc 
contralateral to the injury. Furthermore, we also observed upregulation of receptor gene 
expression covariance early after neuropathic injury. Critically, receptor expression and 
neuropathic pain-related behavioral outcomes were related to long-term fMRI changes. This 
is the first study that provides functional and molecular evidence for the reorganization of 
NAc properties with the transition to neuropathic pain, and demonstrates that disrupting 
NAc neuronal activity reduces expression of neuropathic pain-related behavior.
In healthy anesthetized animals, fMRI revealed that the NAc core and shell exhibited 
extensive connectivity to cortical and sub-cortical regions. Whereas the core had 
significantly stronger connectivity to sensorimotor cortices, insula, cingulate and CPu, the 
shell exhibited stronger connectivity to hippocampus, thalamus, hypothalamus, and mPFC. 
Note that due to MRI signal loss and geometric distortions we could not investigate 
functional connections with the amygdala or with brainstem structures, mainly to ventral 
tegmentum. To our knowledge these results are the first demonstration of functional 
connectivity of NAc in the rodent, demonstrating corticostriatal connections and revealing 
components of the cortico–striato–pallidal–thalamocortical loops [2; 4; 49; 56; 73]. We 
observed prominent connectivity between NAc and CPu, demonstrating the tight coupling 
between parts of basal ganglia related to emotional learning [3; 70] with the dorsal aspects 
involved in more cognitive and motor functions [34; 36]. Significant distinctions were found 
between NAc core and shell in terms of their relative strengths of connectivity, which is 
consistent with their functional segregation along emotional salience and motivated behavior 
[59], their well-established differential connectivity [27; 40; 41; 48], with evidence that the 
two components respond differentially to aversive stimuli [8], and optogenetic data 
indicating dense hippocampal inputs to the medial shell of NAc [17]. Importantly, our 
results point to functional connections between NAc and cortical regions that are important 
in acute and chronic pain, namely, the hippocampus, thalamus, sensorimotor cortices, 
cingulate, insula, mPFC, and OFC, suggesting that the striatal dopaminergic system is part 
of the rearrangement of cortical circuits associated with transition to chronic pain.
An important limitation of this study is the potential influence of anesthesia on reported 
functional connectivity. Strength of functional connectivity is reduced in the anesthetized 
compared to conscious animals [47]. However, the spatial pattern of functional connectivity 
in anesthetized animals seems largely consistent with the pattern observed in awake animals 
[47]. Still, it is likely that fMRI in awake animals may reveal more extensive changes in 
functional connectivity in SNI animals. Another limitation is that we intentionally limited 
the volume and concentration of infused lidocaine to a minimum to insure specificity of 
obtained results. It is likely that the procedure only impacted a limited proportion of NAc, 
especially core, neurons, and that disruption of more NAc neurons would result in bigger 
reductions in neuropathic pain behavior.
The NAc receptor inter-relationships were upregulated in SNI animals at Day5, both within 
the DR1a/DR2 pair, and across the DR1a/DR2 and CB1/5-HT1a pairs. These results suggest 
enhanced dopamine activity within the NAc and VTA reverberating loops. Thus, these 
results are the earliest signal we observe in NAc that differentiate between SNI and sham 
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animals and which imply an enhanced mesolimbic-learning state. Following 28 days of 
neuropathic pain, when expression levels of DR1a, DR2 and KOR in NAc contralateral to 
SNI injury are decreased and NAc functional connectivity is also decreased, the receptor 
inter-relationships seem to return to basal levels, yet with a distinct pattern for SNI. It was 
surprising to see a tight correlation between DR1a and DR2 expression, given that they 
comprise two parallel NAc transmission pathways: DR1a expression defines the 
striatonigral neurons in the direct pathway containing dynorphin, the endogenous ligand for 
KOR; whereas DR2 are expressed on neurons that comprise the striatopallidal indirect 
pathway [2; 25; 30; 32; 58]. The direct and indirect pathways are associated with positive 
hedonic and aversion/negative affect, respectively [15; 52; 57; 58]. Recent studies indicate 
that activation of DR1 and inactivation of DR2 postsynaptically control reward learning and 
aversive learning, respectively, in a pathway-specific manner [39]. If we define transition to 
neuropathic pain as a state of enhanced aversive learning, then we expect to observe changes 
in the expression of DR2. Indeed, 28 days after injury, we in fact observe down regulation of 
DR1a, DR2 and KOR. Furthermore, given that only DR2 expression correlated with 
functional connectivity changes, our data are consistent with the role of aversive-learning 
circuitry in neuropathic pain.
Numerous studies reinforce the notion that levels of dopamine neurotransmission influence 
striatal BOLD activity; for example, the administration of D-amphetamine, dopamine re-
uptake inhibitors, and DR1a or DR2 antagonists all modulate striatal BOLD activity [21; 
28]. Our evidence relating NAc functional connectivity to DR2 expression is consistent with 
these observations and with previous work showing that 1) components of NAc functional 
connectivity and receptor gene expression were dominantly reduced contralaterally at 
Day28, 2) NAc functional connectivity was related to SNI pain behavior and to DR2 
expression, and 3) the disruption of NAc neural activity (chronic perfusion of a DR agonist) 
in NAc attenuates neuropathic behavior in SNI animals [60], which is also consistent with 
our evidence of lidocaine infusion in NAc reducing SNI neuropathic behaviors.
The NAc has been a central site for studying reward and drug reinforcement and for the 
transition between drug use as a reward and as an addictive habit [45; 67]. In fact, the 
reorganization we describe here for neuropathic pain has many parallels to processes 
implicated in addictive behavior. In humans, addicted states are associated with decreased 
DR2 expression in the striatum [69]. Similarly, with sustained neuropathic pain, we observe 
decreased DR2 expression in NAc. In rodent models of addiction, decreased dopamine 
release in the ventral striatum is coupled with increased dopamine release in dorsal striatum 
[72]. Similarly, we observed a decreased synchronization of resting fMRI activity between 
ventral and dorsal striatum, and this de-synchronization was associated with DR2 expression 
in NAc. These parallels are suggestive that brain learning circuitry perpetuate or aid in the 
persistence of pain perception by rendering the perception more habitual, a hypothesis 
derived from current theories of addiction as a shift of cued behavior into a habitual state 
[14]; as such, chronic pain seems to highjack brain learning circuitry in a manner similar to 
addictive behavior. The extent to which addiction to pain shares brain emotional learning 
mechanisms with those for rewarding drugs remains to be determined, and raises the 
question as to whether predisposition to chronic pain is part of a generalized predisposition 
to addictive behavior, or whether it is a specific addictive trait for aversive conditions.
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Fig. 1. Paradigm for Experiment A, and tactile sensitivity changes following peripheral nerve 
injury
(A) MRI scans at baseline were acquired at Day-2. Animals were randomly selected to 
receive either SNI or sham injury (Day 0) and were divided into the Short Term or Long 
Term group. First, at Day5 (Short Term Group, Day5) both SNI and sham animals 
underwent MRI, followed by extraction of NAc tissue for receptor gene expression analysis. 
Similarly, at Day28 (Long Term Group, Day28) SNI and sham animals underwent MRI and 
also extraction of NAc tissue. MRI at Day5 was performed in: SNI=10, sham=12 animals; 
MRI at Day28 was done in: SNI=13, sham=11 animals. RT-qPCR at Day5: was done in 
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SNI=14, sham=13 animals; while at Day28 it was done in: SNI=14, sham=12 animals. 
Because physiological recording was used for fMRI data pre-processing, rats with 
incomplete physiological recordings during the scans were excluded from the fMRI study; 
however these rats were still included in the receptor gene expression analysis. Tests for 
tactile allodynia were performed one day prior to each MRI scan. (B) Tactile allodynia in 
the injury paw of SNI animals were persistent over time. No change in tactile threshold was 
observed in the healthy paw of both SNI and sham animals. Tactile thresholds are shown for 
animals used in MRI experiment illustrated for Experiment A. *P < 0.05.
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Fig. 2. Paradigm of Experiment B
In a different group of animals from Experiment A, NAc activity, contralateral to peripheral 
nerve injury, was disrupted either by infusing Lidocaine 2% (n=8) or saline (n=7), for 14 
days using implanted mini pumps in the NAc. The mini pumps were implanted at the same 
surgical procedure when SNI injury was induced. Behavioral tests for tactile and cold 
allodynia were assessed twice at Day-2 as well as on Day4, Day7, Day10, Day14, Day17 
and Day20.
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Fig. 3. Functional connectivity of NAc core and shell in healthy animals
(A) The core and shell subdivisions of NAc are illustrated, as location of seeds used to study 
functional connectivity of each subdivision. (B) Group-averaged functional connectivity 
maps from NAc core and shell are shown in indicated rows, for resting state fMRI (rs-fMRI) 
when animals were healthy (collected at Day-2). Group-average was across all animals (n = 
36 rats). NAc core and shell exhibited strongest functional connectivity to CPu, S1/2, M1/2, 
Cg, Ins, mPFC and OFC, see Table S1 and Table S2 (one-sample T-test, P < 0.05, family-
wise error (FWE)-corrected). (C) NAc core and shell show preferential functional 
connectivity. The core (core > shell contrast) showed significantly stronger connectivity to 
CPu, S1/2, Cg, Ins, and OFC; while the shell (shell > core contrast) exhibited significantly 
higher connectivity to parts of Hipp, Tha, Hy, and mPFC, see Table 4 and Table 5 (paired T-
test, P < 0.05, FWE-corrected). (D) Brain atlas slices highlighting anatomical borders. 
Columns of axial slices, shown in B-D, correspond to each other (distance from Bregma in 
mm indicated at bottom). Functional connectivity maps are for seeds placed in the right side 
of the brain. Color bars represent range of t-values. Abbreviation: Cg = cingulate cortex, 
CPu = caudate/putamen, Hipp = hippocampus, Hy = hypothalamus, Tha = thalamus, S1/2 = 
primary and secondary S1/2sensory cortices, M1/2 = primary and secondary motor cortices, 
Ins = insular cortex, mPFC = medial prefrontal cortex, OFC = orbital frontal cortex, R = 
right, L = left side of the brain.
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Fig. 4. Differences in functional connectivity of NAc core and shell between SNI and sham 
animals
Between groups functional connectivity contrasts (SNI vs. sham, cross-sectional unpaired 
two-sample t-tests) were significantly different at Day28, illustrated for the four seed 
placements indicated. No significant difference was seen at Day5. (A) At Day28, functional 
connectivity decrease was seen. For contralateral NAc core, connectivity decreased to 
contralateral CPu, bilateral Ins and S1/2, and for ipsilateral NAc core connectivity to the 
contralateral Ins, and bilateral S1/2; while for contralateral NAc shell, connectivity 
decreased to contralateral Ins, and bilateral S1/2, see Table S3 and Table S4. All contrasts 
were thresholded at P < 0.05, FWE-corrected. Color bars represent range of t-values. (B) Rat 
atlas slices corresponding to each column above are shown.
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Fig. 5. The Expression of DR1a, DR2, and KOR transcripts are reduced in the NAc contralateral 
to peripheral nerve injury in SNI animals
(A) Validation of GAPDH primers using dilutions of input NAc cDNA over 4 orders of 
magnitude. The almost perfect doubling of PCR product with each cycle validates this 
primer pair. (B) Representative efficiency curve showing DR1a amplification comprising 
dilutions over 4 orders of magnitude. (C) RT-qPCR products run on a 1.8% agarose gel 
demonstrate a single amplification product for each gene of interest. (D) Relative abundance 
for genes of interest in the NAc of SNI animals are shown, the ipsilateral SNI is normalized 
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to the ipsilateral sham, while the contralateral SNI is normalized to the contralateral sham at 
Day5 and Day 28. Dotted line represents sham levels. For each sample, the gene of interest 
is normalized to the reference gene GAPDH. Alpha tubulin transcripts, when normalized to 
GAPDH, showed no significant changes in contralateral or ipsilateral NAc at Day5 and 
Day28, and validate GAPDH as a stable reference gene. (E) KOR transcript showed no 
significant changes between SNI and sham animals at Day5; however at Day28 a significant 
(P = 0.03), 27% reduction of transcript is found in the contralateral NAc only. (F) DR1a 
transcript showed no significant changes between SNI and sham animals at Day5, but at 
Day28 a significant (P = 0.02), 30% reduction is found in the contralateral NAc only. (G) 
DR2 transcript showed no significant changes between SNI and sham animals at Day5, but 
at Day28 a significant (P = 0.01), 21% reduction was found also in the contralateral NAc. 
No significant changes were found at any timepoint for the MOR, CB1, and 5-HT1a 
receptors (data not shown). Abbreviations: KOR = kappa-opioid receptor, MOR= µ-opioid 
receptor, DR1a = dopamine type 1a receptor, DR2 = dopamine type 2 receptor, CB1 = 
cannabinoid receptor 1, 5-HT1a = serotonin1a receptor, Tubulin = alpha tubulin, GAPDH = 
glyceraldehyde-3-phosphate dehydrogenase, and MW = molecular weight. * P < 0.05. 
(Normalized to GAPDH numbers for qPCR: DR1a: SNI Day5-Ipsi 0.1072, Day5-Contra 
0.0991, sham Day5-Ipsi 0.1172, Day5-Contra 0.1040, SNI Day28-Ipsi 0.1255, Day28-
Contra 0.0889, sham Day28-Ipsi 0.1520, Day28-Contra 0.1479. DR2: SNI Day5-Ipsi 
0.0785, Day5-Contra 0.0720, sham Day5-Ipsi 0.0901, Day5-Contra 0.0820, SNI Day28-Ipsi 
0.0961, Day28-Contra 0.0889, sham Day28-Ipsi 0.1129, Day28-Contra 0.1122. KOR: SNI 
Day5-Ipsi 0.0111, Day5-Contra 0.0106, sham Day5-Ipsi 0.0130, Day5-Contra 0.0188, SNI 
Day28-Ipsi 0.0154, Day28-Contra 0.0136, sham Day28-Ipsi 0.0182, Day28-Contra 0.0187. 
Tubulin: SNI Day5-Ipsi 0.3740, Day5-Contra 0.3750, sham Day5-Ipsi 0.3786, Day5-Contra 
0.3620, SNI Day28-Ipsi 0.4650, Day28-Contra 0.4410, sham Day28-Ipsi 0.4533, Day28-
Contra 0.4636.)
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Fig. 6. Gene expression covariance as a function of injury type and time from injury
Correlations between contralateral and ipsilateral NAc gene transcripts for five receptors 
(DR1a, DR2, KOR, CB1, and 5-HT1a), at a threshold of P < 0.01, are indicated in red 
(positive) and blue (negative) in a network graph representation. We observe a general 
upregulation of covariance between the genes examined in SNI animals at Day5, which 
subsequently subsides to a new state at Day28.
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Fig. 7. In SNI animals, decreased NAc functional connectivity correlates with DR2 receptor gene 
expression and with tactile allodynia
(A) Bar graph shows functional connectivity between NAc core contralateral to injury with 
all of voxels showing significant change and contralateral to injury, while scatter plots show 
correlations between functional connectivity with DR2 gene expression, and with tactile 
allodynia for SNI and sham animals. (B) Bar graph shows the functional connectivity of 
NAc shell contralateral to injury with all of voxels showing significant change and 
contralateral to injury, while scatter plots show the relationship of functional connectivity 
and DR2 gene expressions. Functional connectivity is expressed in Fisher’s z transformed 
correlation coefficients (z(r)), while DR2 receptor expression is expressed in z-scores. Data 
points for correlation analysis were pooled from animals from Day5 and Day28. 
Abbreviation: R = canonical correlation coefficient. #P < 0.05 (post-hoc). *P < 0.05 
(correlation).
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Fig. 8. Disruption of NAc neuronal activity reduces tactile and cold allodynia in SNI animals
(A) Locations of tips of mini pump cannula in NAc contralateral to peripheral nerve injury. 
Majority of tips are localized at medial shell of NAc. (B) Continuous infusion of Lidocaine 
for 14 days significantly reduced tactile allodynia, in comparison to the tactile allodynia of 
saline infused animals during treatment (P = 0.02). After cessation of treatment at Day14, 
the thresholds of the Lidocaine infused animals progressively returned to the levels of saline 
infused animals. (C) Chronic administration of Lidocaine also significantly reduced cold 
allodynia during the treatment period (P = 0.01).
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